The moral corporation
Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970...
Autor principal: | |
---|---|
Otros Autores: | |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Cambridge ; New York :
Cambridge University Press
2006.
|
Colección: | CUP ebooks.
|
Acceso en línea: | Conectar con la versión electrónica |
Ver en Universidad de Navarra: | https://innopac.unav.es/record=b39720184*spi |
Tabla de Contenidos:
- The puzzle
- The professional path
- Turn around
- New drugs and public safety
- Corporate grooming
- Winning in global competition
- Prices and the public interest
- Moral leadership
- Afterwards.